This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends strict targets for blood glucose control to reduce the long-term risks associated with diabetes.
In November 2016, recommendations 1.2.115 and 1.3.52 were amended to add information on when eye screening should begin. Please note the date label of  is unchanged, as this is when the recommendation was written and the evidence last reviewed. The changes made in November 2016 are clarifications of the 2015 wording, not new advice written in 2016, so do not carry a  date.
Who is it for?
- Healthcare professionals that care for children and young people with diabetes
- Commissioners and providers of diabetes services
- Children and young people with type 1 or type 2 diabetes, and their families and carers.
The guideline includes recommendations on:
- management of type 1 and type 2 diabetes
- diagnosis and management of diabetic ketoacidosis in children and young people with type 1 and type 2 diabetes
- service provision.
Guideline development process
This guideline updates and replaces the sections for children and young people in NICE guideline CG15.
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian.
Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.